Understanding drug resistance for monotherapy treatment of HIV infection
From MaRDI portal
Publication:1364700
DOI10.1007/BF02458429zbMath0922.92011WikidataQ44348252 ScholiaQ44348252MaRDI QIDQ1364700
Denise E. Kirschner, Glenn F. Webb
Publication date: 19 October 1999
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Related Items (21)
A mathematical model for HIV treatment with time-varying antiretroviral therapy ⋮ Stochastic investigation of HIV infection and the emergence of drug resistance ⋮ Modeling HIV persistence, the latent reservoir, and viral blips ⋮ Dynamics of a stochastic cell-to-cell HIV-1 model with distributed delay ⋮ Dynamics of the HIV infection under antiretroviral therapy: a cellular automata approach ⋮ Comparison of three kinetic models of HIV-1 infection: implications for optimization of treatment ⋮ The work of Glenn F. Webb ⋮ Emergence of HIV-1 drug resistance during antiretroviral treatment ⋮ Mathematical Modeling of HIV-1 Infection and Drug Therapy ⋮ Global properties of a delayed HIV infection model with CTL immune response ⋮ Threshold virus dynamics with impulsive antiretroviral drug effects ⋮ Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility ⋮ Analysis of global dynamics for HIV-infection of CD4+T cells and its treatment ⋮ A model of HIV-1 pathogenesis that includes an intracellular delay ⋮ Nonautonomous Dynamical Systems in the Life Sciences ⋮ Modeling within-host viral dynamics: the role of CTL immune responses in the evolution of drug resistance ⋮ The effects of distributed life cycles on the dynamics of viral infections ⋮ Dynamics of co-infection with M. tuberculosis and HIV-1 ⋮ A delay-differential equation model of HIV infection of \(\text{CD}4^+\) T-cells ⋮ DYNAMICAL MODEL OF IN-HOST HIV INFECTION: WITH DRUG THERAPY AND MULTI VIRAL STRAINS ⋮ Dynamics of HIV infection on 2D cellular automata
Cites Work
This page was built for publication: Understanding drug resistance for monotherapy treatment of HIV infection